Published online May 15, 2025. doi: 10.4251/wjgo.v17.i5.103127
Revised: January 20, 2025
Accepted: February 5, 2025
Published online: May 15, 2025
Processing time: 187 Days and 5.5 Hours
Core Tip: This retrospective study evaluated inflammatory indicators' predictive significance for relapse-free survival in patients with gastrointestinal stromal tumor (GIST) utilizing a nomogram-based technique. The author tried to associate test preoperative inflammatory indicators with recurrence-free survival. The study created a GIST prognostic nomogram using inflammatory markers, but the limitation(s) and its possible effect on the outcome of GIST prognosis were not discussed. Inclusion and exclusion criteria should be broad enough to minimize the false-positive effects of immune marker levels in test samples. Normalization of inflammatory markers in response to different chemotherapeutic drug(s) is important for obtaining a stable prognostic outcome in GIST.
